Safety Study of COVID19 Vaccine on the Market

NCT05890521 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100000

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cell)

Sponsor

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Collaborators

[object Object]
[object Object]
[object Object]